Short-course eflornithine in Gambian trypanosomiasis: a multicentre randomized controlled trial
OBJECTIVE: A randomized controlled trial was conducted to determine whether 7 days of intravenous eflornithine (100 mg/kg every 6 h) was as effective as the standard 14-day regimen in the treatment of late-stage Trypanosoma brucei gambiense trypanosomiasis. METHODS: A total of 321 patients (274 new...
Main Authors: | Jacques Pépin, Nzambi Khonde, Faustine Maiso, Félix Doua, Shabbar Jaffar, Stéphane Ngampo, Bokelo Mpia, Dawson Mbulamberi, Felix Kuzoe |
---|---|
Format: | Article |
Language: | English |
Published: |
The World Health Organization
2000-11-01
|
Series: | Bulletin of the World Health Organization |
Subjects: | |
Online Access: | http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S0042-96862000001100003&lng=en&tlng=en |
Similar Items
-
Identification of transport systems involved in eflornithine delivery across the blood-brain barrier
by: Christopher P. Watson, et al.
Published: (2023-05-01) -
Specificity of serological screening tests and reference laboratory tests to diagnose gambiense human African trypanosomiasis: a prospective clinical performance study
by: Martial Kassi N’Djetchi, et al.
Published: (2024-07-01) -
Control of human African trypanosomiasis in the Quiçama focus, Angola
by: Ruiz José Antonio, et al.
Published: (2002-01-01) -
Monitoring the elimination of gambiense human African trypanosomiasis in the historical focus of Batié, South–West Burkina Faso
by: Compaoré Charlie Franck Alfred, et al.
Published: (2022-01-01) -
Evaluating the influence of trypanosomiasis on murine model using Corchorus olitorius leaf extract as a trypanocidal agent
by: Madaki Fatima M., et al.
Published: (2024-01-01)